National Bank of Canada’s HUMANIGEN, INC. HGEN Stock Holding History

National Bank of Canada’s Portfolio HGEN Stock Details HGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,200	Closed	-$330	–	2946
2023 Q2	$330	Hold	2,200	–	–	﹤0.01%	2646
2023 Q1	$308	Hold	2,200	–	–	﹤0.01%	2621
2022 Q4	$260	Hold	2,200	–	–	﹤0.01%	2688
2022 Q3	$0	Hold	2,200	–	–	﹤0.01%	2953
2022 Q2	$4K	Hold	2,200	–	–	﹤0.01%	2503
2022 Q1	$7K	Buy	+2,200	New	+$5.89K	﹤0.01%	2492

Other funds holding HGEN

TCM

Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return

DWP

Daymark Wealth Partners Cincinnati, Ohio $4.1B AUM 28.59% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

National Bank of Canada's HGEN Position: Q3 2023 in Review

National Bank of Canada sold out of HUMANIGEN, INC. (HGEN) in Q3 2023, closing a stake of 2,200 shares — an estimated $330 sold.

National Bank of Canada first reported a position in HGEN in Q1 2022 and held it in 6 quarters. The position peaked at $7K in Q1 2022. 3 funds tracked by Wall St. Rank hold HGEN as of Q3 2023.

National Bank of Canada reported no remaining HUMANIGEN, INC. position as of Q3 2023 after selling out during the quarter.
National Bank of Canada sold 2,200 HUMANIGEN, INC. shares in Q3 2023, an estimated $330.
National Bank of Canada first reported a position in HUMANIGEN, INC. in Q1 2022 and held it in 6 quarters.
National Bank of Canada's HUMANIGEN, INC. position peaked at $7K in Q1 2022.
3 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q3 2023.

Based on National Bank of Canada's 13F filing for Q3 2023, filed 10 Oct 2023.